CITADEL ADVISORS LLC 13D and 13G filings for Spruce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
CITADEL ADVISORS LLC | 108,240 0.300% |
-1,639,151 (-93.81%) |
Filing |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
CITADEL ADVISORS LLC | 1,747,391 7.400% |
12,322 (+0.71%) |
Filing |
| 2022-02-14 06:12 am Purchase |
2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
CITADEL ADVISORS LLC | 1,735,069 7.400% |
33,282 (+1.96%) |
Filing |
| 2021-02-16 4:30 pm Unchanged |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
CITADEL ADVISORS LLC | 1,701,787 7.300% |
0 (Unchanged) |
Filing |
| 2020-10-26 4:01 pm Purchase |
2020-10-14 | 13G | Spruce Biosciences, Inc. SPRB |
CITADEL ADVISORS LLC | 1,701,787 7.300% |
1,701,787 (New Position) |
Filing |